[1]
|
Smith, E., Ruszkiewicz, A.R., Jamieson, G.G. and Drew, P.A. (2014) IGFBP7 Is Associated with Poor Prognosis in Oesophageal Adenocarcinoma and Is Regulated by Promoter DNA Methylation. British Journal of Cancer, 110, 775-782.
https://doi.org/10.1038/bjc.2013.783
|
[2]
|
Hojman, P., Gehl, J., Christensen, J.F. and Pedersen, B.K. (2018) Mo-lecular Mechanisms Linking Exercise to Cancer Prevention and Treatment. Cell Metabolism, 27, 10-21. https://doi.org/10.1016/j.cmet.2017.09.015
|
[3]
|
Jin, L., Shen, F., Weinfeld, M. and Sergi, C. (2020) Insulin Growth Factor Binding Protein 7 (IGFBP7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk. Frontiers in Oncology, 10, Article 727. https://doi.org/10.3389/fonc.2020.00727
|
[4]
|
Hwa, V., Oh, Y. and Rosenfeld, R.G. (1999) The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily. Endocrine Reviews, 20, 761-787. https://doi.org/10.1210/edrv.20.6.0382
|
[5]
|
Akiel, M., Guo, C., Li, X., Rajasekaran, D., Mendoza, R.G., Robert-son, C.L., Jariwala, N., Yuan, F., Subler, M.A., Windle, J., Garcia, D.K., Lai, Z., Chen, H.H., Chen, Y., Giashuddin, S., Fisher, P.B., Wang, X.Y. and Sarkar, D. (2017) IGFBP7 Deletion Promotes Hepatocellular Carcinoma. Cancer Re-search, 77, 4014-4025.
https://doi.org/10.1158/0008-5472.CAN-16-2885
|
[6]
|
Bach, L.A. (2018) What Happened to the IGF Binding Proteins? Endocrinology, 159, 570-578.
https://doi.org/10.1210/en.2017-00908
|
[7]
|
Wang, S., Chi, K., Wu, D. and Hong, Q. (2021) Insulin-Like Growth Factor Binding Proteins in Kidney Disease. Frontiers in Pharmacology, 12, Article 807119. https://doi.org/10.3389/fphar.2021.807119
|
[8]
|
López-Bermejo, A., Khosravi, J., Corless, C.L., Krishna, R.G., Diamandi, A., Bodani, U., Kofoed, E.M., Graham, D.L., Hwa, V. and Rosenfeld, R.G. (2003) Generation of An-ti-Insulin-Like Growth Factor-Binding Protein-Related Protein 1 (IGFBP-rP1/MAC25) Monoclonal Antibodies and Immunoassay: Quantification of IGFBP-rP1 in Human Serum and Distribution in Human Fluids and Tissues. The Jour-nal of Clinical Endocrinology and Metabolism, 88, 3401-3408. https://doi.org/10.1210/jc.2002-021315
|
[9]
|
Creemers, A., Ebbing, E.A., Pelgrim, T.C., Lagarde, S.M., van Et-ten-Jamaludin, F.S., van Berge Henegouwen, M.I., Hulshof, M.C.C.M., Krishnadath, K.K., Meijer, S.L., Bijlsma, M.F., van Oijen, M.G.H. and van Laarhoven, H.W.M. (2018) A Systematic Review and Meta-Analysis of Prognostic Bi-omarkers in Resectable Esophageal Adenocarcinomas. Scientific Reports, 8, Article No. 13281. https://doi.org/10.1038/s41598-018-31548-6
|
[10]
|
Kashyap, M.K., Pawar, H.A., Keerthikumar, S., Sharma, J., Goel, R., Mahmood, R., Kumar, M.V., Kumar, K.V., Pandey, A., Kumar, R.V., Prasad, T.S. and Harsha, H.C. (2013) Evaluation of Protein Expression Pattern of Stanniocalcin 2, Insulin-Like Growth Factor-Binding Protein 7, Inhibin Beta a and Four and a Half LIM Domains 1 in Esophageal Squamous Cell Carcinoma. Cancer Biomarkers, 12, 1-9. https://doi.org/10.3233/CBM-120289
|
[11]
|
Huang, X., Hong, C., Peng, Y., Yang, S., Huang, L., Liu, C., Chen, L., Chu, L., Xu, L. and Xu, Y. (2019) The Diagnostic Value of Serum IGFBP7 in Patients with Esophageal Squamous Cell Carcinoma. Journal of Cancer, 10, 2687- 2693. https://doi.org/10.7150/jca.32393
|
[12]
|
Li, X., Zhang, J., Wu, Y., Ma, C., Wei, D., Pan, L. and Cai, L. (2022) IGFBP7 Remodels the Tumor Microenvironment of Esophageal Squamous Cell Carcinoma by Activating the TGFβ1/SMAD Signaling Pathway. Oncology Letters, 24, Article No. 251. https://doi.org/10.3892/ol.2022.13371
|
[13]
|
Chen, Y.-B., Liao, X. Y., Zhang, J.B., Wang, F., Qin, H. D., Zhang, L., Shugart, Y.Y., Zeng, Y.-X. and Jia, W.-H. (2017) ADAR2 Functions as a Tumor Suppressor via Editing IGFBP7 in Esophageal Squamous Cell Carcinoma. International Journal of Oncology, 50, 622-630. https://doi.org/10.3892/ijo.2016.3823
|
[14]
|
Zhao, Q., Zhao, R., Song, C., Wang, H., Rong, J., Wang, F., Yan, L., Song, Y. and Xie, Y. (2021) Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer. Journal of Cancer, 12, 1343-1355.
https://doi.org/10.7150/jca.50370
|
[15]
|
Liu, Q., Jiang, J., Zhang, X., Zhang, M. and Fu, Y. (2021) Comprehensive Analysis of IGFBPs as Biomarkers in Gastric Cancer. Frontiers in Oncology, 11, Article 723131. https://doi.org/10.3389/fonc.2021.723131
|
[16]
|
Sato, Y., Inokuchi, M., Takagi, Y., Otsuki, S., Fujimori, Y., Yanaka, Y., Kobayashi, K., Higuchi, K., Kojima, K. and Kawano, T. (2015) Relationship between Expression of IGFBP7 and Clinicopathological Variables in Gastric Cancer. Journal of Clinical Pathology, 68, 795-801. https://doi.org/10.1136/jclinpath-2015-202987
|
[17]
|
Yoshioka, T., Shien, K., Namba, K., Torigoe, H., Sato, H., Tomida, S., Yamamoto, H., Asano, H., Soh, J., Tsukuda, K., Nagasaka, T., Fujiwara, T. and Toyooka, S. (2018) Anti-tumor Activity of Pan-HER Inhibitors in HER2-Positive Gastric Cancer. Cancer Science, 109, 1166-1176. https://doi.org/10.1111/cas.13546
|
[18]
|
Liu, L., Yang, Z., Zhang, W., Yan, B., Gu, Q., Jiao, J. and Yue, X. (2014) Decreased Expression of IGFBP7 Was a Poor Prognosis Predictor for Gastric Cancer Patients. Tumour Biology, 35, 8875-8881.
https://doi.org/10.1007/s13277-014-2160-1
|
[19]
|
Kim, J., Kim, W.H., Byeon, S.J., Lee, B.L. and Kim, M.A. (2018) Epigenetic Downregulation and Growth Inhibition of IGFBP7 in Gastric Cancer. Asian Pacific Journal of Cancer Pre-vention, 19, 667-675.
|
[20]
|
Georges, R.B., Adwan, H., Hamdi, H., Hielscher, T., Linnemann, U. and Berger, M.R. (2011) The Insulin-Like Growth Factor Binding Proteins 3 and 7 Are Associated with Colorectal Cancer and Liver Me-tastasis. Cancer Biology & Therapy, 12, 69-79. https://doi.org/10.4161/cbt.12.1.15719
|
[21]
|
Shao, L., Huang, Q., Luo, M. and Lai, M. (2004) Detection of the Differentially Expressed Gene IGF-Binding Protein-Related Protein-1 and Analysis of Its Relationship to Fasting Glucose in Chinese Colorectal Cancer Patients. Endocrine-Related Cancer, 11, 141-148. https://doi.org/10.1677/erc.0.0110141
|
[22]
|
Li, Y., Xi, Y., Zhu, G., Jia, J., Huang, H., Liu, Y., Guo, Y. and Liu, L. (2019) Downregulated IGFBP7 Facilitates Liver Metastasis by Modulating Epithelial-Mesenchymal Transi-tion in Colon Cancer. Oncology Reports, 42, 1935-1945.
https://doi.org/10.3892/or.2019.7303
|
[23]
|
Ruan, W., Wang, Y., Ma, Y., Xing, X., Lin, J., Cui, J. and Lai, M. (2010) HSP60, a Protein Downregulated by IGFBP7 in Colorectal Carcinoma. Journal of Experimental & Clinical Can-cer Research, 29, Article No. 41.
https://doi.org/10.1186/1756-9966-29-41
|
[24]
|
Lin, J., Lai, M., Huang, Q., Ma, Y., Cui, J. and Ruan, W. (2007) Methylation Patterns of IGFBP7 in Colon Cancer Cell Lines Are Associated with Levels of Gene Expression. The Jour-nal of Pathology, 212, 83-90.
https://doi.org/10.1002/path.2144
|
[25]
|
Suzuki, H., Igarashi, S., Nojima, M., Maruyama, R., Yamamoto, E., Kai, M., Akashi, H., Watanabe, Y., Yamamoto, H., Sasaki, Y., Itoh, F., Imai, K., Sugai, T., Shen, L., Issa, J.P., Shinomura, Y., Tokino, T. and Toyota, M. (2010) IGFBP7 Is a p53-Responsive Gene Specifically Silenced in Colorectal Cancer with CpG Island Methylator Phenotype. Carcinogenesis, 31, 342-349. https://doi.org/10.1093/carcin/bgp179
|
[26]
|
Rao, C., Lin, S.-L., Ruan, W.-J., Wen, H., Wu, D.-J. and Deng, H. (2014) High Expression of IGFBP7 in Fibroblasts In-duced by Colorectal Cancer Cells Is Co-Regulated by TGF-β and Wnt Signaling in a Smad2/3-Dvl2/3-Dependent Man-ner. PLOS ONE, 9, e85340. https://doi.org/10.1371/journal.pone.0085340
|
[27]
|
Zhu, S., Zhang, J., Xu, F., Xu, E., Ruan, W., Ma, Y., Huang, Q. and Lai, M. (2015) IGFBP-rP1 Suppresses Epithelial-Mesenchymal Transition and Me-tastasis in Colorectal Cancer. Cell Death & Disease, 6, e1695.
https://doi.org/10.1038/cddis.2015.59
|
[28]
|
Qiu, B., Chu, L.Y., Li, X.X., Peng, Y.H., Xu, Y.W., Xie, J.J. and Chen, X.Y. (2020) Diagnostic Value of Serum Insulin-Like Growth Factor Binding Protein 7 (IGFBP7) in Colorectal Cancer. OncoTargets and Therapy, 13, 12131- 12139. https://doi.org/10.2147/OTT.S266478
|
[29]
|
Chen, D., Yoo, B.K., Santhekadur, P.K., Gredler, R., Bhutia, S.K., Das, S.K., Fuller, C., Su, Z.Z., Fisher, P.B. and Sarkar, D. (2011) Insulin-Like Growth Factor-Binding Protein-7 Functions as a Potential Tumor Suppressor in Hepatocellular Carcinoma. Clinical Cancer Research, 17, 6693-6701. https://doi.org/10.1158/1078-0432.CCR-10-2774
|
[30]
|
Tomimaru, Y., Eguchi, H., Wada, H., Kobayashi, S., Marubashi, S., Tanemura, M., Umeshita, K., Kim, T., Wakasa, K., Doki, Y., Mori, M. and Nagano, H. (2012) IGFBP7 Downregulation Is Associated with Tumor Progression and Clinical Outcome in Hepatocellular Carcinoma. International Journal of Cancer, 130, 319-327.
https://doi.org/10.1002/ijc.25994
|
[31]
|
Li, F., Fan, Y.-C., Gao, S., Sun, F.-K., Yang, Y. and Wang, K. (2014) Methylation of Serum Insulin-Like Growth Factor-Binding Protein 7 Promoter in Hepatitis B Virus-Associated Hepato-cellular Carcinoma. Genes, Chromosomes and Cancer, 53, 90-97. https://doi.org/10.1002/gcc.22120
|
[32]
|
Chen, D., Siddiq, A., Emdad, L., Rajasekaran, D., Gredler, R., Shen, X.N., Santhekadur, P.K., Srivastava, J., Robertson, C.L., Dmitriev, I., Kashentseva, E.A., Curiel, D.T., Fisher, P.B. and Sarkar, D. (2023) Retraction Notice to: Insulin-Like Growth Factor-Binding Protein-7 (IGFBP7): A Promising Gene Therapeutic for Hepatocellular Carcinoma (HCC). Mo-lecular Therapy, 31, 599. https://doi.org/10.1016/j.ymthe.2022.12.019
|
[33]
|
Brindley, P.J., Bachini, M., Ilyas, S.I., Khan, S.A., Loukas, A., Sirica, A.E., Teh, B.T., Wongkham, S. and Gores, G.J. (2021) Cholangiocarcinoma. Nature Re-views Disease Primers, 7, Article No. 65.
https://doi.org/10.1038/s41572-021-00300-2
|
[34]
|
Yue, C., Yang, M., Tian, Q., Mo, F., Peng, J., Ma, Y., Huang, Y., Wang, D., Wang, Y. and Hu, Z. (2018) IGFBP7 Is Associated to Prognosis and Could Suppress Cell Survival in Cholangiocarcinoma. Artificial Cells, Nanomedicine, and Biotechnology, 46, 817-825. https://doi.org/10.1080/21691401.2018.1470524
|
[35]
|
Hu, J.-X., Zhao, C.-F., Chen, W.-B., Liu, Q.-C., Li, Q.-W., Lin, Y.-Y. and Gao, F. (2021) Pancreatic Cancer: A Review of Epidemiology, Trend, and Risk Factors. World Journal of Gastroenterology, 27, 4298-4321.
https://doi.org/10.3748/wjg.v27.i27.4298
|
[36]
|
An, W., Ben, Q.-W., Chen, H.-T., Zheng, J.-M., Huang, L., Li, G.-X. and Li, Z.-S. (2012) Low Expression of IGFBP7 Is Associated with Poor Outcome of Pancreatic Ductal Adeno-carcinoma. Annals of Surgical Oncology, 19, 3971-3978.
https://doi.org/10.1245/s10434-012-2407-2
|